These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35465238)

  • 1. Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
    Suttels V; André P; Thoma Y; Veuve F; Decosterd L; Guery B; Buclin T
    JAC Antimicrob Resist; 2022 Apr; 4(2):dlac043. PubMed ID: 35465238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients.
    Mena M; Garcia JC; Bustos RH
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?
    Li L; Sassen SDT; Ewoldt TMJ; Abdulla A; Hunfeld NGM; Muller AE; de Winter BCM; Endeman H; Koch BCP
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity.
    Venugopalan V; Casaus D; Kainz L; Slaton CN; Hurst N; Bruzzone M; Hu C; Sword G; Cherabuddi K; Iovine N; Liu J; Scheetz MH; Rhodes N; Maranchick N; Peloquin CA; Klinker K; Alshaer MH
    Pharmacotherapy; 2023 Jan; 43(1):6-14. PubMed ID: 36401796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoring.
    Oda K; Saito H; Jono H
    Pharmacol Ther; 2023 Jun; 246():108433. PubMed ID: 37149156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure.
    Wills KH; Behan SJ; Nance MJ; Dawson JL; Polasek TM; Hopkins AM; van Dyk M; Rowland A
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056943
    [No Abstract]   [Full Text] [Related]  

  • 7. Individualized dosing of vancomycin in geriatric patients.
    Suchánková H; Lečbychová K; Strojil J; Fürst T
    Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients.
    Kallee S; Scharf C; Schatz LM; Paal M; Vogeser M; Irlbeck M; Zander J; Zoller M; Liebchen U
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study.
    Hui KHM; Lam HS; Chow CHT; Li YSJ; Leung PHT; Chan LYB; Lee CP; Ewig CLY; Cheung YT; Lam TNT
    JMIR Med Inform; 2022 Jan; 10(1):e29458. PubMed ID: 35099393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.
    Gotta V; Widmer N; Montemurro M; Leyvraz S; Haouala A; Decosterd LA; Csajka C; Buclin T
    Clin Pharmacokinet; 2012 Mar; 51(3):187-201. PubMed ID: 22339450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia.
    Gijsen M; Bekkers B; Maertens J; Lagrou K; Desmet S; Dreesen E; Peetermans WE; Debaveye Y; Spriet I
    Int J Antimicrob Agents; 2022 Jan; 59(1):106472. PubMed ID: 34757136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package.
    Chaudhri K; Stocker SL; Williams KM; McLeay RC; Marriott DJE; Di Tanna GL; Day RO; Carland JE
    J Antimicrob Chemother; 2020 Jul; 75(7):1981-1984. PubMed ID: 32277819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study.
    Boschung-Pasquier L; Atkinson A; Kastner LK; Banholzer S; Haschke M; Buetti N; Furrer DI; Hauser C; Jent P; Que YA; Furrer H; Babouee Flury B
    Clin Microbiol Infect; 2020 Mar; 26(3):333-339. PubMed ID: 31284030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
    Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
    J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
    Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Time above the MIC Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO).
    Kois AK; Gluck JA; Nicolau DP; Kuti JL
    Int J Antimicrob Agents; 2022 Jul; 60(1):106603. PubMed ID: 35577257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults.
    Gastmans H; Dreesen E; Wicha SG; Dia N; Spreuwers E; Dompas A; Allegaert K; Desmet S; Lagrou K; Peetermans WE; Debaveye Y; Spriet I; Gijsen M
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.